Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Sotorasib dosing and incremental cost ineffectiveness - implications and lessons for stakeholders.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Sotorasib dosing and incremental cost ineffectiveness - implications and lessons for stakeholders.
Sotorasib dosing and incremental cost ineffectiveness - implications and lessons for stakeholders. Nat Rev Clin Oncol. 2024 May; 21(5):331-332.
View in:
PubMed
subject areas
Antineoplastic Agents
Cost-Benefit Analysis
Drug Costs
Humans
authors with profiles
Mark J. Ratain